Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05023278
PHASE4

The Use of Venlafaxine in Reducing Pain in Primary Total Knee Replacement

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

Patients experience pain after their knee replacement surgery - and some may continue to experience persistent pain long after their knee replacement surgery. Traditional pain management strategies reply on pain medication such as opioids for pain control. However, these drugs do not work well for pain associated with movement or the the nerve pain (tingling, electrical sensations) after surgery. In addition, opioids are associated with significant side effects such as nausea, vomiting, respiratory depression, depression, cognitive dysfunction and risk of persistent opioid use. Neuropathic pain medications, such as venlafaxine are effective in managing nerve pain. Recent studies also support its potential role in acute pain management. Here, we propose a prospective randomized clinical trial 1) to evaluate the efficacy of Venlafaxine in reducing pain intensity and opioid consumption at post-operative day 1 (POD1) and 1- week after surgery, and 2) to examine whether the use of Venlafaxine will reduce the incidents of chronic postsurgical pain in TKA patients at 3-month time point.

Official title: The Use of Venlafaxine in Reducing Acute Post-Surgical Pain and Opioid Consumption in Primary Total Knee Replacement

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2021-05-10

Completion Date

2025-03-31

Last Updated

2026-11-10

Healthy Volunteers

Yes

Interventions

DRUG

Venlafaxine 37.5 MG

venlafaxine 37.5mg daily for 7 consecutive days.

DRUG

Placebo

placebo filled pill daily for 7 consecutive days.

Locations (1)

University of California San Francisco

San Francisco, California, United States